{"title":"Oncology","description":null,"products":[{"product_id":"nanoerythrocytes-in-cancer-therapy-advancing-targeted-chemotherapy-and-theranostics","title":"Nanoerythrocytes in Cancer Therapy: Advancing Targeted Chemotherapy and Theranostics","description":"\u003cp\u003eby Bharti Mangla (ed.), Kanchan Kohli (ed.) This book explores the theranostic potential of nanoerythrocytes against cancer. It provides a comprehensive overview, beginning with the evolution of erythrocytes into nanoerythrocytes and their crucial role as advanced drug delivery systems in oncology. It addresses the challenges in developing nanoerythrocytes, from safety and scalability to regulatory concerns. It provides a thorough examination of formulation strategies and technological advancements, covering the design, engineering, and optimization of nanoerythrocytes for precise drug delivery. Through case studies, recent patents, and clinical trials, this book reveals the latest advancements and future directions in the field. Furthermore, the chapters discuss the immune responses triggered by nanoerythrocytes and their implications for cancer treatment. Key Features: Explores the theranostic potential of nanoerythrocytes, integrating therapeutic and diagnostic capabilities of nanoerythrocytes for personalized cancer treatment Provides detailed insights into the design, drug loading, and release mechanisms that optimize nanoerythrocytes for targeted cancer therapies Investigates immune responses to nanoerythrocyte-based treatments, focusing on safety and efficacy in cancer therapy Addresses key development challenges—safety, scalability, and regulatory—of using nanoerythrocytes against cancer Discusses the latest innovations, patents, and trial outcomes of theranostic potential of nanoerythrocytes against cancer This book is a useful resource for researchers working in cancer biology, pharmaceutical sciences, and biomedical sciences.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537471746289,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040407370-1.jpg?v=1786384488"},{"product_id":"advancements-in-cancer-theranostics-integrating-imaging-and-intervention","title":"Advancements in Cancer Theranostics: Integrating Imaging and Intervention","description":"\u003cp\u003eby Rajendra Prasad (ed.), Murali Mohan Yallapu (ed.) This book addresses the recent developments, trends, and challenges of nanosized biomedicine for solid tumors with reference to FDA approved imaging and therapeutic agents. In the last 25 years, about 300 nanosized imaging and therapeutic probes have been registered for clinical trials and only about 25 have qualified the necessary needs of FDA approval. None of the books or articles published so far cover the wide range of nanomedicine examples with multimode imaging and therapeutic applications. This book addresses this gap by discussing various examples of surface engineered functional nano(bio)medicine along with their challenges. This book covers the road map of cancer nanomedicine by focusing on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples of site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutic approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, (vii) requirements for clinical trials and FDA approval etc etc. The book covers these key topics by comprising of various chapters from well-establish research groups focusing on surface chemistry, oncomedicine, multimode diagnostics and therapeutics, and nanomedicines. Thus, this book aims to provide a comprehensive validation of cancer nanomedicine for advanced therapeutic approaches. This book is targeted at biomedical scientists, oncologists, researchers and graduate students in the domains of nanomedicine and nanotheranostics.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537481609457,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819509386.jpg?v=1786384516"},{"product_id":"molecular-mechanisms-of-action-of-polyphenols-against-cancer-experimental-and-in-silico-evaluations","title":"Molecular Mechanisms of Action of Polyphenols Against Cancer: Experimental and in silico Evaluations","description":"\u003cp\u003eby J. Basilio Heredia (ed.), Nayely Leyva-López (ed.), Laura Aracely Contreras-Angulo (ed.), Jayanta Kumar Patra (ed.), Erick Paul Gutiérrez Grijalva (ed.) Recent and ongoing epidemiological studies point to the beneficial health effects of dietary polyphenols, with evidence suggesting that individuals with a high intake of polyphenol-rich foods have less incidence of noncommunicable diseases like diabetes, cardiovascular problems, and cancer. Multidisciplinary research on dietary polyphenols and what causes them to exert such benefits has led to discoveries which can help us to understand the mechanisms of action of these molecules, including the structure-activity relationships of polyphenols, the modulatory effects exerted on enzymes, reactive oxygen species, protein interactions, and the regulation of expression of some transcription factors. In recent years, increased interest in bioinformatic studies has helped scientists predict and evaluate the interactions of polyphenols with protein targets involved in the onset and development of different types of cancer. Likewise, in silico evaluations coupled with experimental studies are a rising trend in many research areas. This contributed volume critically summarizes the experimental and in silico molecular mechanisms of action of dietary polyphenols, including phenolic acids, anthocyanins, flavanols, flavanones, and flavones against cancer. It is designed for researchers in academia and industry focused on cancer immunology and therapeutics, medicinal chemistry, and food science (functional foods, nutraceuticals, natural products, food technology), as well as graduate students preparing for a career in these areas.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537486491889,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9783031996016.jpg?v=1786384531"},{"product_id":"emerging-trends-in-phytotherapy-of-cancer","title":"Emerging Trends in Phytotherapy of Cancer","description":"\u003cp\u003eby Mahendra Rai PhD (ed.), Shandesh Bhattarai PhD (ed.) Emerging Trends in Phytotherapy of Cancer is an essential reference that explores the multifaceted role of medicinal plants in combating cancer. The book covers a broad range of interconnected topics including ethnomedicinal plants used in cancer by tribes and aboriginals, herbs used in Ayurvedic medicine for cancer, integrated approaches of modern and conventional drugs, anti-cancerous secondary metabolites, plant-based anticancer drugs approved by FDA and WHO, toxicity to humans, and the role of emerging technologies such as the applications of nanotechnology and artificial intelligence. The contents are divided into six parts. Part one opens with an introductory chapter, followed by the different combinations of plant-based drugs and modern medicine for cancer treatment, and recent developments in cancer research. Part two discusses the ethnomedicinal uses of plants in cancer and the role of Ayurvedic herbal medicines in cancer. Part three incorporates the role of secondary metabolites in cancer treatment. Part four elaborates on the plant-based drugs recommended by FDA\/WHO. Part five concerns the human phytotoxicity of secondary metabolites, and part six describes the role of emerging nanotechnologies and artificial intelligence in phytotherapy drug delivery and treatment. Targeted at researchers, healthcare professionals, and advanced students in related fields, this book provides technical and in-depth knowledge, contributing to ongoing advancements in cancer treatment. It uniquely integrates ethnomedicinal therapies with modern technologies, offering a comprehensive overview of the research into phytomedicinal cancer therapies. - Explores the therapeutic potential of medicinal plants in cancer treatment - Highlights the role of secondary metabolites in combating cancer - Integrates ethnomedicinal therapies with modern technologies like nanotechnology and AI - Provides technical insights for researchers, healthcare professionals, and advanced students\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537487737073,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9780443405129.jpg?v=1786384535"},{"product_id":"nanotheranostics-in-metabolic-syndrome-transforming-diagnosis-and-therapeutics","title":"Nanotheranostics in Metabolic Syndrome: Transforming Diagnosis and Therapeutics","description":"\u003cp\u003eby Vivek K. Chaturvedi (ed.), Anurag Kumar Singh (ed.), Jay Singh (ed.), Dawesh P. Yadav (ed.) This book explores the potential of nanotechnology in treating metabolic disorders, highlighting its potential to improve drug delivery, early disease detection, and precision therapeutics. Metabolic syndrome is a significant global health challenge, with a five-fld increase in the risk of developing type-2 diabetes and a two-fold heightened risk of cardiovascular diseases. Despite advancements in understanding the pathogenesis of metabolic syndrome, current therapeutic interventions have not achieved optimal efficacy. The integration of nanotechnology into biomedicine is seen as a promising avenue to address this issue. Nanoparticles can be engineered to carry anti-inflammatory agents, providing targeted relief at inflammation sites, reducing inflammation and minimizing systemic side effects. Nanotechnology also enhances drug delivery systems by navigating biological barriers and reaching specific sites with precision. This not only improves the bioavailability of therapeutic agents but also minimizes off-target effects, enhancing overall treatment effectiveness. Nanotechnology also plays a pivotal role in early disease detection and diagnosis through innovative nano-imaging techniques. These techniques enable the visualization of molecular and cellular events at unprecedented resolutions, facilitating the identification of metabolic syndrome markers and associated disorders at their incipient stages. As research progresses, the integration of nanotechnology has the potential to redefine metabolic syndrome management, offering hope for improved patient outcomes and a healthier global population. The chapters cover metabolic syndromes, including insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease. It provides up-to-date literature on mechanistic understanding and therapeutic strategies. It is a valuable resource for UG\/PG students, clinicians, academicians, scientists, researchers, and industrial specialists in advanced materials science, flexible electronics, nanoelectronics, energy, environmental, and biomedical sciences.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537499074801,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819537464.jpg?v=1786384566"},{"product_id":"personalized-medicine-in-oncology","title":"Personalized Medicine in Oncology","description":"\u003cp\u003eby Priya Hays This book covers the field of precision oncology and is aligned with the targeted therapy drug development paradigm. Chapters present the relevance of immunotherapies as important and pivotal treatment strategies for cancer. The book outlines how Immune checkpoint inhibitors, CAR T cell therapies, antibody drug conjugates and bispecific antibodies evolved through the conduct of clinical trials and the resulting data to become critical components of the oncologist’s armamentarium. The mechanism of each class is described in detail and how each has advantages and limitations concerning existing standards of care, demonstrating that they complement and contrast with each other; resistance mechanisms are also discussed. Targeted therapies for solid tumors and hematologic malignancies are explained in-depth. The roles of cancer genomics and liquid biopsy for precision oncology are also explored. This book sufficiently fills a gap by coalescing these studies into a thorough, yet clear compendium of these therapies. It describes the prognostic and predictive significance of each drug, biomarkers for determining their therapeutic potential, along with the assays (e.g., IHC) that evaluate them. Personalized Medicine in Oncology is a valuable resource for oncologists and clinicians as well as graduate medical students, cancer nurse practitioners, pharmacists, and clinicians in other related therapeutic areas of interest.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537520505073,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9783032144362.jpg?v=1786384627"},{"product_id":"nano-theragnostics-in-breast-cancer","title":"Nano Theragnostics in Breast Cancer","description":"\u003cp\u003eby Rishabha Malviya (ed.), Sathvik Belagodu Sridhar (ed.), Musarrat Husain Warsi (ed.) This contributed volume explores the revolutionary impact of nanotechnology on breast cancer therapy, namely through the pioneering domain of nano-theragnostic. It emphasises the transformation of personalised medicine through the integration of diagnostics and therapy with nanomaterials. It analyses the influence of the tumour microenvironment on cancer advancement, particularly on metastasis. It discusses innovative diagnostic instruments, including sophisticated biosensors and liquid biopsy, that facilitate early diagnosis and accurate monitoring. Innovative therapeutic techniques, such as nanoparticles, liposomes, carbon nanotubes, and quantum dots, are examined for their potential to enhance diagnostic and therapy efficacy. The book highlights the importance of surmounting obstacles such as drug resistance and examines methods like photothermal and photodynamic therapy. The exploration includes the role of AI in improving diagnosis and therapy, as well as the importance of lifestyle modifications and psychological factors in cancer care. This book presents unique insights into the transformative potential of nanotechnology in breast cancer therapy, offering renewed hope for both patients and healthcare professionals. It is an insightful read for researchers, scientists as well as practitioners.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537522241777,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819536818.jpg?v=1786384633"},{"product_id":"advances-in-stimuli-responsive-nanosystems-for-cancer-therapy","title":"Advances in Stimuli-Responsive Nanosystems for Cancer Therapy","description":"\u003cp\u003eby Padma V. Devarajan (ed.), Sathish Dyawanapelly (ed.), Vijayabhaskarreddy Junnuthula (ed.) The book is a compilation of the latest developments in the technology and applications of stimuli-responsive nanosystems for cancer therapy. The book begins with an overview of recent advances in various stimuli, including endogenous triggers related to tumor microenvironments such as pH, temperature, enzymes and exogenous stimuli such as light, temperature, ultrasound and magnetic field, which could significantly augment anticancer therapy. A gamut of nanosystems investigated for cancer therapy, some major systems being liposomes, polymer nanoparticles, lipid nanoparticles, inorganic nanoparticles, hybrid nanoparticles and a range of other nanosystems which are stimuli responsive are covered in detail in the subsequent chapters. The chapters comprehensively cover the various nanosystems from development to evaluation to their application.  This book is a valuable resource for scientists, professors, researchers, as well as medical and industry professionals working in the area of cancer and targeted drug delivery.  It is also proposed as a textbook for master’s students opting for a course in targeted drug delivery\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537522929905,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819527434.jpg?v=1786384635"},{"product_id":"enzyme-based-approaches-in-cancer-healthcare-management","title":"Enzyme Based Approaches in Cancer Healthcare Management","description":"\u003cp\u003eby Dalapathi Gugulothu (ed.), Sushama Talegaonkar (ed.), Lalit Kumar (ed.) This book offers an in-depth analysis of enzyme-based approaches in healthcare management, focusing on their transformative potential in cancer treatment. This volume delves into the intricate roles of enzymes in cancer progression and targeted therapy. The book addresses a wide range of subjects, such as the functions of important enzymes in the biology of cancer, developments in targeting telomerase, the cell cycle, angiogenesis, and metastasis, and the possibility of using topoisomerase and PARP inhibitors to take advantage of weaknesses in cancer cells. It provides an in-depth analysis of non-glycolytic and glycolytic enzymes, tumor-driven angiogenesis, epigenetic regulation, and advanced therapeutic approaches, including nanotechnology and bispecific antibodies. It addresses key questions such as how enzymes contribute to cancer metabolism and how novel therapeutic strategies can exploit these pathways for more accurate and less dangerous cancer medicines. The book covers expert analyses of key enzymes involved in cancer biology, including hexokinase, phosphofructokinase-1, and matrix metalloproteinases. This book is an invaluable resource for researchers, clinicians, and professionals in the pharmaceutical and biotechnology industries. It offers a comprehensive overview of the molecular mechanisms underlying enzyme function in cancer and the development of innovative enzyme-targeted treatments. It is a must-read for those seeking to advance their understanding of enzyme-based healthcare management.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537523028209,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819550708.jpg?v=1786384636"},{"product_id":"novel-therapeutic-targeting-in-cancer-an-interdisciplinary-approach","title":"Novel Therapeutic Targeting in Cancer: An Interdisciplinary Approach","description":"\u003cp\u003eby Nima Rezaei (ed.) The “Novel Therapeutic Targeting in Cancer: An Interdisciplinary Approach” is the twenty sixth volume of the “Interdisciplinary Cancer Research” series, publishes comprehensive volume on novel therapeutic targeting in cancer. The volume starts with a chapter on telomere, DNA damage response, and nanomedicine, as a triad for cancer treatment innovation, followed by two general chapters on precision oncology and interdisciplinary pathways for cancer treatment. Advanced targeting systems for tissue-specific drug delivery and new-generation drug delivery systems as anticancer strategies are the subjects of the following chapters. After discussion on targeting inflammatory proteins for inhibition of cell proliferation in tumor microenviroment, small RNAs, microRNAs, as well as implementing CRISPR\/Cas9 and microbiota genomics are explained. Targeting glycan, lectin-based targeted drug delivery systems, proteolysis targeting chimeras, dihydrofolate reductase inhibitors, PARP, ATR, RUVBL1\/2 complex, and metal-coordination complexes in cancer treatment are explained in other chapters. Finally, computational advancements and in vitro evaluation in pre-clinical anticancer drug discovery and development are discussed in the last chapter. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for those who wish to have an update on cancer therapeutic targeting.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537523159281,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9783032144003.jpg?v=1786384637"},{"product_id":"clinical-landscape-in-cancer-research-advanced-topics-in-biomaterials","title":"Clinical Landscape in Cancer Research (Advanced Topics in Biomaterials)","description":"\u003cp\u003eBy Ranjita Shegokar Ph.D., Yashwant Pathak PhD. Cancer, a multifaceted disease, remains the leading cause of death worldwide. Ongoing research and technological advancements are continually improving the human understanding of newer treatment options. This book series aims to provide wide-ranging insights into the current landscape of cancer research, highlighting the recent advancements, current challenges, and future directions. Cancer varies widely in its formation, microenvironment, location in the body, associated risk factors, detection methodology, and treatment approaches. Early detection and prevention through lifestyle changes, regular screenings, and the awareness of symptoms are crucial for improving outcomes and survival rates. In this book series, the main focus is on trending topics, like new drug delivery, diagnostics, biomarkers, and preclinical and clinical developments in cancer research. Nanotechnology has emerged as a transformative approach in medicine, particularly in the areas of targeted drug delivery systems, imaging, and diagnostics to enhance the therapeutic efficacy and minimize adverse effects in cancer therapy. Advances in pharma, medical device, and diagnostic research, including the development of Trojan-horse therapies and precision treatments\/assay kits, continue to enhance the effectiveness of cancer care over the past few decades. A total of five books are covered in this series: Drug Delivery Landscape in Cancer Research (Vol. 1) Biomarker Landscape in Cancer Research (Vol. 2) Diagnostic Landscape in Cancer Research (Vol. 3) Preclinical Landscape in Cancer Research (Vol. 4) Clinical Landscape in Cancer Research (Vol. 5) By integrating basic, applied, and innovative science concepts, this book series fosters a deeper understanding of the disease and paves the way for the development of more effective strategies. This book series serves as a valuable resource for students, researchers, regulators, and clinicians interested in understanding the complexities of cancer and the innovative approaches researched to combat this deadly disease. Nonetheless, continuous interdisciplinary, cross-country collaborations and cross-science innovation strategies are essential to further reduce the global cancer burden. Contains current studies of the clinical research of different cancer types Provides essential information on the most recent developments in clinical cancer research Explains current technology and its applications of clinical cancer research Holds contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers Product Details Publisher ‏ : ‎ Academic Press; 1st edition (May 30, 2025) Language ‏ : ‎ English Paperback ‏ : ‎ 342 pages ISBN-10 ‏ : ‎ 0443302197 ISBN-13 ‏ : ‎ 978-0443302190\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537555796209,"sku":null,"price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/978-0443302190-9780443302206.webp?v=1786384875"},{"product_id":"polysaccharide-biomaterials-in-cancer-research-and-therapy-from-lab-to-life","title":"Polysaccharide Biomaterials in Cancer Research and Therapy: From Lab to Life","description":"\u003cp\u003eby Luqman Jameel Rather (ed.), Showkat Ali Ganie (ed.), Mohammed A. Assiri (ed.) Revolutionize your approach to oncology with this guide to mastering the interdisciplinary intersection of green chemistry and clinical research, where polysaccharide-based innovations provide a safer, biocompatible, and sustainable frontier for cancer treatment. Cancer continues to be a major global health issue, impacting millions of individuals annually. Although traditional cancer treatments have improved, there is a rising demand for alternative and complementary medicines that may provide advantages with fewer side effects. Polysaccharides, which are complex sugars found in plants, fungi, and microbes, are considered for cancer research and treatment because of their many biological effects, compatibility with living organisms, and low toxicity. In recent years, the area of polysaccharide-based cancer treatment has seen substantial expansion. This book provides a thorough summary of the present status of research and advancements in polysaccharide-based cancer treatment. It delves into the interdisciplinary and rapidly evolving field of biomedical research that intersects with pharmaceutics, oncology, and materials science. There is a growing focus on treatment methods that are both more sustainable and safer, in line with the ideas of green chemistry and personalized medicine. This book documents a crucial stage in the advancement of various fields, including materials science, biotechnology, and clinical oncology, offering new therapies that are better aligned with the human body and the environment. Readers will find the volume: Introduces the structural features, properties, and biological effects of polysaccharides that are pertinent to cancer research and treatment; Examines recent progress in polysaccharide-based drug delivery technologies, immunomodulatory effects, and targeted therapeutic strategies; Showcases case studies, clinical trials, and translational research that illustrate the efficacy of polysaccharides in enhancing treatment results and patient well-being; Discusses obstacles, possibilities, and future directions for advancing research using polysaccharide-based cancer treatments; Acts as a resource for anyone interested in the function of polysaccharides in cancer research and therapy, promoting multidisciplinary cooperation. Audience Academics, researchers, and professionals in oncology, biomedical engineering, nanotechnology, and drug delivery systems, specifically cancer researchers, biotechnologists, pharmaceutical scientists, and clinicians interested in biomaterials and advanced therapeutic strategies.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537573359857,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781394345458.jpg?v=1786384990"},{"product_id":"personalized-cancer-therapy-advances-in-precision-medicine-for-targeted-cancer-treatment","title":"Personalized Cancer Therapy: Advances in Precision Medicine for Targeted Cancer Treatment","description":"\u003cp\u003eby Mrinal K. Ghosh (ed.), Malini Basu (ed.) This book offers a definitive and comprehensive exploration of precision medicine, capturing both its foundational principles and cutting-edge innovations. Organized into six sections, it guides readers from the basics of individualized healthcare to the advanced application of genomics, epigenomics, pharmacogenomics, and artificial intelligence in cancer treatment. Through detailed cancer-specific chapters—covering gliomas, head \u0026amp; neck cancers, breast, lung, prostate, colon, pancreatic, and other malignancies—the book delivers in-depth insights into molecular profiling, diagnosis, and personalized therapy strategies. Beyond scientific advances, it critically addresses the ethical, clinical, and social dimensions of precision medicine, preparing clinicians, researchers, and policymakers to navigate challenges and harness the future opportunities in this transformative field. By blending scientific rigor with forward-looking perspectives, this volume positions itself as an authoritative reference for oncology researchers, clinicians, bioinformaticians, pharmaceutical scientists, and graduate students seeking to understand and contribute to the future of personalized healthcare.\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537573654769,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9789819568444.jpg?v=1786384998"},{"product_id":"polysaccharides-in-cancer-therapy","title":"Polysaccharides in Cancer Therapy","description":"\u003cp\u003eby Shakeel Ahmed (ed.), Meghraj Vivekanand Suryawanshi (ed.) This book provides a thorough overview of the clinical applications of polysaccharides in cancer therapy. It explores diverse types and intricate molecular structures of polysaccharides and examines their immunomodulatory properties and inherent potential as potent anticancer agents. The book also presents pharmacokinetic and pharmacodynamic properties of polysaccharides in cancer therapy, shedding light on their dynamic interactions within the body and their impact on cancer cells. It also discusses how polysaccharides can enhance traditional chemotherapy and radiation therapy outcomes, leading to more effective cancer treatment strategies. Additionally, it uncovers the vital role of polysaccharides in the burgeoning fields of cancer immunotherapy, targeted therapy, and cancer prevention, offering insights into their potential to reduce cancer risk. The integration of nanotechnology for precision drug delivery and the emerging field of theranostics are also discussed, highlighting practical clinical applications. Additionally, the book addresses crucial safety and regulatory considerations, underscores ethical and societal aspects, and elucidates the stringent regulatory approval processes governing polysaccharide-based cancer therapies. This book is intended for researchers in the fields of cancer, biomedical sciences, and pharmacology. KEY FEATURES: Provides an overview of the clinical applications of polysaccharides in cancer therapy Explores the diverse types and intricate molecular structures of polysaccharides Presents insights into the immunomodulatory properties of polysaccharides and their significant role in cancer treatment Illuminates the dynamic interactions of polysaccharides within the body, highlighting their influence on cancer cells Addresses crucial safety considerations and the stringent regulatory approval processes governing polysaccharide-based cancer therapies\u003c\/p\u003e","brand":"Pharmacology \u0026 Pharmacy","offers":[{"title":"Default Title","offer_id":48537574080753,"sku":null,"price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0811\/0211\/0961\/files\/9781040435885.jpg?v=1786385009"}],"url":"https:\/\/pharmalibrary.online\/collections\/oncology.oembed","provider":"Pharma","version":"1.0","type":"link"}